Stock RP REPLICEL LIFE SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart RepliCel Life Sciences Inc. Toronto S.E.

Equities

RP

CA76027P4006

Delayed Toronto S.E.
Other stock markets
 11:00:00 2024-04-16 am EDT 		5-day change 1st Jan Change
0.055 CAD -.--% Intraday chart for RepliCel Life Sciences Inc. -21.43% -15.38%
May. 31 RepliCel Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 17 RepliCel Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 119B
ARGENX SE Stock argenx SE
 27.95B -
BIONTECH SE Stock BioNTech SE
 20.5B -
GENMAB A/S Stock Genmab A/S
 17.12B
  1. Stock Market
  2. Equities
  3. REPCF Stock
  4. RP Stock
  5. Charts RepliCel Life Sciences Inc.
  6. Sector Chart